Association between 1p11-rs11249433 Polymorphism and Breast Cancer Susceptibility: Evidence from 15 Case-Control Studies

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wu, Sheng ^a   Cai, Jungang ^a   Wang, Hong ^a   Zhang, Hongwei ^a   Yang, Weige ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AFRICA; AFRICAN; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; RISK ASSESSMENT; BREAST TUMOR; CHROMOSOME 1; CONFIDENCE INTERVAL; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 1; CONFIDENCE INTERVALS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 84881601359     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072526     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005). CA Cancer J Clin 55: 74-108. doi:10.3322/canjclin.55.2.74. PubMed: 15761078.
2. McPherson K, Steel CM, Dixon JM, (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321: 624-628. doi:10.1136/bmj.321.7261.624. PubMed: 10977847.
3. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101,986 women without the disease. Lancet 358: 1389-1399. doi:10.1016/S0140-6736(01)06524-2. PubMed: 11705483.
4. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85. doi:10.1056/NEJM200007133430201. PubMed: 10891514.
5. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. (1994) A strong candidate for the breast and ovarian-cancer susceptibility gene BRCA1. Science 266: 66-71. doi:10.1126/science.7545954. PubMed: 7545954.
6. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, et al. (1995) Identifi{ligature}cation of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792. doi:10.1038/378789a0. PubMed: 8524414.
7. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39: 165-167. doi:10.1038/ng1959. PubMed: 17200668.
8. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31: 55-59. doi:10.1038/ng879. PubMed: 11967536.
9. Erkko H, Xia B, Nikkilä J, Schleutker J, Syrjäkoski K, et al. (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446: 316-319. doi:10.1038/nature05609. PubMed: 17287723.
10. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, et al. (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38: 873-875. doi:10.1038/ng1837. PubMed: 16832357.
11. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, et al. (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38:1239-1241.
12. Antoniou AC, Easton DF, (2006) Models of genetic susceptibility to breast cancer. Oncogene 25: 5898-5905. doi:10.1038/sj.onc.1209879. PubMed: 16998504.
13. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, et al. (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41: 579-584. doi:10.1038/ng.353. PubMed: 19330030.
14. Li DW, Collier DA, He L, (2006) Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15: 1995-2002. doi:10.1093/hmg/ddl122. PubMed: 16687441.
15. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129. doi:10.2307/3001666.
16. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833.
17. Woolf B, (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19: 251-253. doi:10.1111/j.1469-1809.1955.tb01348.x. PubMed: 14388528.
18. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101. doi:10.2307/2533446. PubMed: 7786990.
19. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. doi:10.1136/bmj.315.7109.629. PubMed: 9310563.
20. Bhatti P, Doody MM, Rajaraman P, Alexander BH, Yeager M, et al. (2010) Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. Radiol Technol Radiat Res 173: 214-224. doi:10.1667/RR1985.1.
21. Long J, Shu XO, Cai Q, Gao YT, Zheng Y, et al. (2010) Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 19: 2357-2365. doi:10.1158/1055-9965.EPI-10-0054. PubMed: 20699374.
22. Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, et al. (2011) Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20: 4693-4706. doi:10.1093/hmg/ddr368. PubMed: 21852249.
23. Chen F, Chen GK, Millikan RC, John EM, Ambrosone CB, et al. (2011) Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Hum Mol Genet 20: 4491-4503. doi:10.1093/hmg/ddr367. PubMed: 21852243.
24. Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, et al. (2011) Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 20: 3304-3321. doi:10.1093/hmg/ddr226. PubMed: 21593217.
25. Hutter CM, Young AM, Ochs-Balcom HM, Carty CL, Wang T, et al. (2011) Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study. Cancer Epidemiol Biomarkers Prev 20: 1950-1959. doi:10.1158/1055-9965.EPI-11-0524. PubMed: 21795501.
26. Jiang Y, Shen H, Liu X, Dai J, Jin G, et al. (2011) Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women. PLOS ONE 6: e21563. doi:10.1371/journal.pone.0021563. PubMed: 21738711.
27. Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, et al. (2011) Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst 103: 1252-1263. doi:10.1093/jnci/djr265. PubMed: 21791674.
28. Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, et al. (2011) Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 71: 6240-6429. doi:10.1158/0008-5472.CAN-11-1266. PubMed: 21844186.
29. Li J, Humphreys K, Heikkinen T, Aittomäki K, Blomqvist C, et al. (2011) A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat 126: 717-727. doi:10.1007/s10549-010-1172-9. PubMed: 20872241.
30. Sueta A, Ito H, Kawase T, Hirose K, Hosono S, et al. (2012) A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res Treat 132: 711-721. doi:10.1007/s10549-011-1904-5. PubMed: 22160591.
31. Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, et al. (2012) Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis 33: 835-840. doi:10.1093/carcin/bgs093. PubMed: 22357627.
32. He C, Chasman DI, Dreyfus J, Hwang SJ, Ruiter R, et al. (2012) Reproductive aging-associated common genetic variants and the risk of breast cancer. Breast Cancer Res 14: R54. doi:10.1186/bcr3155. PubMed: 22433456.
33. Kim HC, Lee JY, Sung H, Choi JY, Park SK, et al. (2012) A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 14: R56. doi:10.1186/bcr3158. PubMed: 22452962.
34. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869. doi:10.1038/ng2064. PubMed: 17529974.
35. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40: 703-706. doi:10.1038/ng.131. PubMed: 18438407.
36. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, et al. (2005) Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 97: 439-448. doi:10.1093/jnci/dji064. PubMed: 15770008.
37. Li CI, Malone KE, Daling JR, (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11: 601-607. PubMed: 12101106.
38. Milne RL, Goode EL, García-Closas M, Couch FJ, Severi G, et al. (2011) Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 20: 2222-2231. doi:10.1158/1055-9965.EPI-11-0569. PubMed: 21795498.
39. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, et al. (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLOS Genet 4: e1000054. PubMed: 18437204.
40. Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, et al. (2010) NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations. Mol Cancer 9: 113. doi:10.1186/1476-4598-9-113. PubMed: 20482849.